Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

NCT00875394 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: sitagliptin phosphate
DRUG: Comparator: metformin
DRUG: Comparator: metformin
DRUG: Comparator: Antidiabetic Standard of Care

Sponsor

Merck Sharp & Dohme LLC